This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk Healthcare Ag. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovations of Hans Holmegaard Sørensen
Introduction
Hans Holmegaard Sørensen is a notable inventor based in Virum, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of human growth hormone. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Hans holds a patent for a pharmaceutical formulation that includes human growth hormone, histidine, poloxamer, phenol, and mannitol. This formulation is designed to enhance the stability and efficacy of the hormone, which is crucial for its therapeutic use. He has 1 patent to his name, reflecting his focused contributions to the field.
Career Highlights
Hans is currently employed at Novo Nordisk Healthcare AG, a leading company in diabetes care and hormone replacement therapies. His role at Novo Nordisk allows him to work on cutting-edge research and development projects that aim to improve patient outcomes.
Collaborations
Throughout his career, Hans has collaborated with esteemed colleagues such as Søren Bjørn and Peter Langballe. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Hans Holmegaard Sørensen exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the formulation of human growth hormone, highlight the critical role of inventors in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile